Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2014 Aug 26.
Published in final edited form as: J Acquir Immune Defic Syndr. 2010 Aug;54(4):e3–e4. doi: 10.1097/QAI.0b013e3181da1270

Suicidal Ideation is Associated with HIV Transmission Risk in Men who Have Sex with Men

Adam W Carrico 1, Torsten B Neilands 1, Mallory O Johnson 1
PMCID: PMC4144977  NIHMSID: NIHMS449992  PMID: 20611031

Even in the era of anti-retroviral therapy (ART), the suicide rate remains elevated among HIV-positive persons.1 Individuals who are at increased risk for suicide often have a more pessimistic, hopeless view of the future2, 3 and tend to preferentially attend to immediate sensations.4 These cognitive changes promote behavioral disinhibition, which places one at higher risk for attempting suicide and may also increase engagement in other risk taking behaviors.5 The present cross-sectional investigation with 232 HIV-positive men who have sex with men (MSM) examined a cognitive escape model of HIV transmission risk behavior.6 Suicidal ideation was conceptualized as a vulnerability factor that is accompanied by a constellation of cognitive changes that predisposes individuals to behavioral disinhibition. Consequently, we hypothesized that participants experiencing suicidal ideation would report increased rates of HIV transmission risk behavior after controlling for other cognitive and affective symptoms of depression. Because stimulant use has been associated with an increased likelihood of engaging in HIV transmission risk behavior,7, 8 it was examined as a releasing stimulus that may explain the relationship between suicidal ideation and HIV transmission risk.

Methods

The present study utilized data from 232 HIV-positive MSM who reported elevated ART-related side effect burden (i.e., the upper 40% of composite side effect burden scores).9 Assessments were conducted using computer-assisted interviewing methods to enhance the veracity of self-reported suicidal ideation, sexual risk taking, and substance use.10 Suicidal ideation and depressive symptoms were measured using the 21-item Beck Depression Inventory II (BDI-II).11 One BDI-II item assessing suicidal ideation was dichotomized to reflect any thoughts of self harm. Drawing on an investigation examining the psychometric properties of the BDI-II,12 we calculated a modified 7-item BDI-Cognitive subscale (Cronbach’s α = .85) that excluded the suicidal ideation item. Because HIV-related symptoms and somatic depressive symptoms are confounded, we also calculated a modified 7-item BDI-Affective (i.e., sadness, loss of pleasure, crying, agitation, loss of interest, indecisiveness, irritability) subscale (Cronbach’s α = .78). For HIV transmission risk, participants completed a brief sex risk measure that assesses the total number of partners, number of partners without a condom, and number of unprotected sex partners who were HIV-positive during the past 3 months. Indices of HIV transmission risk during anal intercourse included: 1) any HIV transmission risk as the insertive partner; 2) any HIV transmission risk as the receptive partner; and 3) any HIV transmission risk (insertive or receptive). Weekly stimulant use was classified as reporting use of cocaine, crack, or methamphetamine once a week or more on average during the past 3 months.

Results

Most participants identified as gay (89%) or bisexual (9%). The majority of participants were Caucasian (60%), but a sizeable proportion of participants were Hispanic/Latino (17%) or African American (11%). Mean age was 46.4 (SD = 7.8) years, and individuals had been diagnosed with HIV for 14.1 (SD = 6.0) years on average. The mean self-reported T-helper (CD4+) cell count was 415 (SD = 253) and 34% reported having a detectable HIV viral load.

Approximately 28% of participants (66/232) reported thoughts of suicide in the past two weeks, and 3% (7/232) indicated they would like to kill themselves or would kill themselves if they had the chance. We also estimated that 16% of participants reported any HIV transmission risk behavior with 12% reporting transmission risk as the receptive partner and 9% reporting transmission risk as the insertive partner. Eight percent of participants reported using stimulants at least weekly. As shown in Table 1, binary logistic regression analyses indicated that suicidal ideation was independently associated with greater than a 2-fold increase in the odds of reporting any HIV transmission risk (26% vs. 12%). Suicidal ideation was not associated with transmission risk as the receptive partner (17% vs. 10%), but it was independently associated with almost a 3-fold increase in the odds of reporting HIV transmission risk as the insertive partner (15% versus 6%). Findings also indicated that for every 1 standard deviation increase in the modified composite score of cognitive symptoms of depression, the odds of reporting HIV transmission risk as the insertive partner were 89% higher. Suicidal ideation was also independently associated with more than a 3-fold increase in the odds of reporting stimulant use at least weekly (15% vs. 5%). Finally, mediation analyses indicated that stimulant use did not explain the relationship between suicidal ideation and any HIV transmission risk (β = .04, 95% CI = −.01 – .15, p > .10) or the relationship between suicidal ideation and transmission risk as the insertive partner (β = .06, 95% CI = −.01 – .19, p > .10).

Table 1.

Logistic Regression Analyses for Indices of HIV Transmission Risk and Weekly Stimulant Use (N = 232)

Any
Transmission Risk
URAI UIAI At Least Weekly
Stimulant Use
AOR 95% CI AOR 95% CI AOR 95% CI AOR 95% CI
Time since HIV Diagnosis 0.99 0.93 – 1.05 0.98 0.92 – 1.05 1.03 0.95 – 1.12 0.96 0.89 – 1.04
Caucasian 1.00 Reference 1.00 Reference 1.00 Reference 1.00 Reference
African American 0.62 0.17 – 2.26 0.55 0.12 – 2.56 1.25 0.25 – 6.37 0.83 0.17 – 4.01
Hispanic/Latino 0.63 0.22 – 1.82 0.51 0.14 – 1.87 1.68 0.47 – 6.06 0.65 0.17 – 2.52
Other Ethnic Minority 1.09 0.36 – 3.26 0.83 0.22 – 3.13 3.00 0.79 – 11.38 0.30 0.04 – 2.48
BDI-Affective 0.74 0.45 – 1.22 0.85 0.49 – 1.47 0.55 0.28 – 1.07 1.29 0.70 – 2.36
BDI-Cognitive 1.34 0.85 – 2.10 1.57 0.96 – 2.57 1.89* 1.07 – 3.36 0.74 0.39 – 1.41
Suicidal Ideation 2.44* 1.08 – 5.55 1.45 0.56 – 3.76 2.93* 1.01 – 8.49 3.10* 1.03 – 9.31

URAI = Unprotected Receptive Anal Intercourse with HIV-negative or unknown status partners;

UIAI = Unprotected Insertive Anal Intercourse with HIV-negative or unknown status partners;

AOR = Adjusted Odds Ratio;

p < .10;

*

p < .05

Discussion

To our knowledge, the present study is the first to observe that individuals experiencing suicidal ideation may be more likely to engage in HIV transmission risk behavior. Other cognitive symptoms of depression (including pessimism) were also independently associated with HIV transmission risk behavior as the insertive partner during anal intercourse. These findings stand in stark contrast to a meta-analysis of 34 published studies which observed that depressive symptoms were not reliably associated with HIV transmission risk behavior.13 Depression is multi-faceted clinical condition with cognitive, affective, and somatic dimensions. Although affective (e.g., sadness) and somatic (e.g., fatigue) symptoms of depression may be obstacles to engaging in sexual intercourse,14 findings from the present study indicate that suicidal ideation and other cognitive symptoms of depression may predispose individuals to engaging in HIV transmission risk. Although cognitive symptoms of depression appear to be a key vulnerability factor that may contribute to HIV transmission risk, this does not appear to be due to increased rates of weekly stimulant use. However, bearing in mind that stimulant users on ART display elevated HIV viral load,15, 16 behavioral interventions that address the cooccurrence of stimulant use and HIV transmission risk among individuals experiencing suicidal ideation could reduce HIV transmission rates.17 Clinicians treating HIV-positive MSM who are experiencing suicidal ideation should also systematically assess concomitant substance use and HIV transmission risk behavior in order to provide targeted prevention counseling where appropriate.

Further research is needed to examine the pathways that account for increased rates of HIV transmission risk behavior among those experiencing suicidal ideation. One previous cross-sectional investigation observed that individuals experiencing suicidal ideation were more likely to report non-disclosure of their HIV serostatus.18 Although non-disclosure of HIV serostatus has associated with an increased likelihood of reporting HIV transmission risk behavior,7 there was not a direct association between suicidal ideation and HIV transmission risk.18 Non-disclosure of HIV status should be evaluated as a plausible mediator of the relationship between suicidal ideation and HIV transmission risk in future longitudinal research. Results of the present investigation should also be interpreted in light of the inclusion criteria. HIV-positive MSM were invited to participate because they reported elevated ART-related side effect burden, which was associated with higher levels of neuroticism in our prior work.9 Neuroticism is a relatively stable personality trait that provides an index of the extent to which individuals are prone to experiencing negative affect across various situational contexts. Elevated levels of trait neuroticism among participants in this study may have strengthened the observed association between cognitive symptoms of depression and risk taking behaviors.

Acknowledgements

This research was funded by grants from the National Institute of Mental Health (R01 MH068208; K24MH087220; Johnson, PI).

References

  • 1.Keiser O, Spoerri A, Brinkhof MWG, et al. Suicide in HIV-infected individuals and the general population, Switzerland 1988-2008. American Journal of Psychiatry. doi: 10.1176/appi.ajp.2009.09050651. in press. [DOI] [PubMed] [Google Scholar]
  • 2.Rosenfeld B, Breitbart W, Gibson C, et al. Desire for hastened death among patients with advanced AIDS. Psychosomatics. 2006 Nov-Dec;47(6):504–512. doi: 10.1176/appi.psy.47.6.504. [DOI] [PubMed] [Google Scholar]
  • 3.Beck AT, Steer RA, Kovacs M, Garrison B. Hopelessness and eventual suicide: a 10-year prospective study of patients hospitalized with suicidal ideation. Am J Psychiatry. 1985 May;142(5):559–563. doi: 10.1176/ajp.142.5.559. [DOI] [PubMed] [Google Scholar]
  • 4.Baumeister RF. Suicide as escape from self. Psychol Rev. 1990 Jan;97(1):90–113. doi: 10.1037/0033-295x.97.1.90. [DOI] [PubMed] [Google Scholar]
  • 5.Carrico AW. The suicide rate remains elevated among HIV-positive persons in the era of anti-retroviral therapy: Implications for a stress and coping model of suicide. American Journal of Psychiatry. doi: 10.1176/appi.ajp.2009.09111565. in press. [DOI] [PubMed] [Google Scholar]
  • 6.McKirnan DJ, Ostrow DG, Hope B. Sex, drugs and escape: a psychological model of HIV-risk sexual behaviours. AIDS Care. 1996 Dec;8(6):655–669. doi: 10.1080/09540129650125371. [DOI] [PubMed] [Google Scholar]
  • 7.Morin SF, Steward WT, Charlebois ED, et al. Predicting HIV transmission risk among HIV-infected men who have sex with men: findings from the healthy living project. J Acquir Immune Defic Syndr. 2005 Oct 1;40(2):226–235. doi: 10.1097/01.qai.0000166375.16222.eb. [DOI] [PubMed] [Google Scholar]
  • 8.Johnson MO, Carrico AW, Chesney MA, Morin SF. Internalized heterosexism among HIV-positive, gay-identified men: implications for HIV prevention and care. J Consult Clin Psychol. 2008 Oct;76(5):829–839. doi: 10.1037/0022-006X.76.5.829. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Johnson MO, Neilands TB. Neuroticism, Side Effects, and Health Perceptions Among HIV-Infected Individuals on Antiretroviral Medications. J Clin Psychol Med Settings. 2007 Mar;14(1):69–77. doi: 10.1007/s10880-007-9056-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Des Jarlais DC, Paone D, Milliken J, et al. Audio-computer interviewing to measure risk behaviour for HIV among injecting drug users: a quasi-randomised trial. Lancet. 1999 May 15;353(9165):1657–1661. doi: 10.1016/s0140-6736(98)07026-3. [DOI] [PubMed] [Google Scholar]
  • 11.Beck AT, Steer RA, Ball R, Ranieri W. Comparison of Beck Depression Inventories -IA and -II in psychiatric outpatients. J Pers Assess. 1996 Dec;67(3):588–597. doi: 10.1207/s15327752jpa6703_13. [DOI] [PubMed] [Google Scholar]
  • 12.Steer RA, Ball R, Ranieri WF, Beck AT. Dimensions of the Beck Depression Inventory-II in clinically depressed outpatients. J Clin Psychol. 1999 Jan;55(1):117–128. doi: 10.1002/(sici)1097-4679(199901)55:1<117::aid-jclp12>3.0.co;2-a. [DOI] [PubMed] [Google Scholar]
  • 13.Crepaz N, Marks G. Are negative affective states associated with HIV sexual risk behaviors? A meta-analytic review. Health Psychol. 2001 Jul;20(4):291–299. doi: 10.1037//0278-6133.20.4.291. [DOI] [PubMed] [Google Scholar]
  • 14.Nobre PJ, Pinto-Gouveia J. Dysfunctional sexual beliefs as vulnerability factors to sexual dysfunction. J Sex Res. 2006 Feb;43(1):68–75. doi: 10.1080/00224490609552300. [DOI] [PubMed] [Google Scholar]
  • 15.Carrico AW, Johnson MO, Morin SF, et al. Stimulant use is associated with immune activation and depleted tryptophan among HIV-positive persons on anti-retroviral therapy. Brain Behav Immun. 2008 Aug 3; doi: 10.1016/j.bbi.2008.07.010. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Cook JA, Burke-Miller JK, Cohen MH, et al. Crack cocaine, disease progression, and mortality in a multicenter cohort of HIV-1 positive women. Aids. 2008 Jul 11;22(11):1355–1363. doi: 10.1097/QAD.0b013e32830507f2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Dieffenbach CW, Fauci AS. Universal voluntary testing and treatment for prevention of HIV transmission. Jama. 2009 Jun 10;301(22):2380–2382. doi: 10.1001/jama.2009.828. [DOI] [PubMed] [Google Scholar]
  • 18.Sherr L, Lampe F, Fisher M, et al. Suicidal ideation in UK HIV clinic attenders. Aids. 2008 Aug 20;22(13):1651–1658. doi: 10.1097/QAD.0b013e32830c4804. [DOI] [PubMed] [Google Scholar]

RESOURCES